Literature DB >> 9315966

Controversies surrounding glucocorticoid-mediated cell death in the hippocampus.

L P Reagan1, B S McEwen.   

Abstract

The adrenal gland releases mineralocorticoids (MCs) and glucocorticoids (GCs) in response to a variety of stimuli, including stress. Once released, these adrenal steroids mediate a plethora of physiological responses in both the periphery and the central nervous system. The collective actions of GCs in the brain are paradoxical, however, in that basal levels of GCs are essential for neuronal development, plasticity and survival, while stress levels of GCs produce neuronal loss. Aging represents another contradictory function of GCs in the brain, since lifelong exposure to GCs has been implicated as a causative factor in senescent neuronal loss. In addition, glucocorticoids have also been shown to intensify neuronal damage in the hippocampus during ischemia and excitotoxicity through mechanisms that modulate synaptic glutamate concentrations. Conversely, the absence of adrenal steroids has been shown to regulate both neurogenesis and neuronal loss in the dentate gyrus of the hippocampus. Evidence continues to accumulate which suggests that GC-induced neuronal death in all these physiological and pathophysiological settings occurs by apoptosis. Accordingly, this review will examine the pharmacological, cellular and molecular mechanisms through which glucocorticoids mediate or contribute to neuronal remodeling and, ultimately, neuronal death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315966     DOI: 10.1016/s0891-0618(97)00031-8

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  49 in total

Review 1.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Depression, antidepressants, and the shrinking hippocampus.

Authors:  R M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B.

Authors:  Kevin Chen; Xiao-Ming Ou; Jason Boyang Wu; Jean C Shih
Journal:  Mol Pharmacol       Date:  2010-10-27       Impact factor: 4.436

4.  Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.

Authors:  U S Sandau; R J Handa
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

5.  Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.

Authors:  Anil Kumar; Beenta Kumari; Puneet Kumar
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

Review 6.  Annual review prize lecture cytokines - killers in the brain?

Authors:  N J Rothwell
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

7.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 8.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

9.  Thyroid hormones are associated with poorer cognition in mild cognitive impairment.

Authors:  Patrick Quinlan; Arto Nordlund; Karin Lind; Deborah Gustafson; Ake Edman; Anders Wallin
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-26       Impact factor: 2.959

10.  Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study.

Authors:  Thomas Frodl; Markus Jäger; Ivana Smajstrlova; Christine Born; Ronald Bottlender; Tanja Palladino; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.